Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer

BACKGROUND: Consolidation durvalumab improved overall survival (OS) in locally advanced non-small cell lung cancer (LA-NSCLC) treated with chemoradiotherapy (CRT) in the PACIFIC trial; however, pneumonitis was increased with durvalumab. We sought to examine real-world outcomes with the PACIFIC parad...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassanzadeh, Comron, Sita, Timothy, Savoor, Rohan, Samson, Pamela P., Bradley, Jeffrey, Gentile, Michelle, Roach, Michael, Mohindra, Nisha, Waqar, Saiama, Kruser, Timothy J., Robinson, Clifford
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711405/
https://www.ncbi.nlm.nih.gov/pubmed/33282370
http://dx.doi.org/10.21037/jtd-20-1792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711405/
https://www.ncbi.nlm.nih.gov/pubmed/33282370
http://dx.doi.org/10.21037/jtd-20-1792

Ejemplares similares